Association Between<i>NRAS</i>and<i>BRAF</i>Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma
2015 · JAMA Oncology · 190 citations
https://doi.org/10.1001/jamaoncol.2015.0493
S
Sharon N. Edmiston
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
123
Papers
5.5K
Citations
21
h-index
35
i10-index
Sharon N. Edmiston is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: Cutaneous Melanoma Detection and Management & Melanoma and MAPK Pathways & CAR-T cell therapy research. The author has an h-index of 21, co-authored 105 publications.
ORCID: 0000-0001-8273-446XPapers by this author
worksDNA methylation profiling in the Carolina Breast Cancer Study defines cancer subclasses differing in clinicopathologic characteristics and survival
2014 · Breast Cancer Research · 93 citations
https://doi.org/10.1186/s13058-014-0450-6
The estrogen receptor-α A908G (K303R) mutation occurs at a low frequency in invasive breast tumors: results from a population-based study
2005 · Breast Cancer Research · 56 citations
https://doi.org/10.1186/bcr1315
Racial Variation in Breast Tumor Promoter Methylation in the Carolina Breast Cancer Study
2015 · Cancer Epidemiology Biomarkers & Prevention · 51 citations
https://doi.org/10.1158/1055-9965.epi-14-1228
Utility of TERT Promoter Mutations for Cutaneous Primary Melanoma Diagnosis
2018 · American Journal of Dermatopathology · 44 citations
https://doi.org/10.1097/dad.0000000000001259
<scp>DNA</scp> methylation profiles in primary cutaneous melanomas are associated with clinically significant pathologic features
2014 · Pigment Cell & Melanoma Research · 23 citations
https://doi.org/10.1111/pcmr.12289
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat